Clinical Trial: Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07848204) titled 'Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors' on Sept. 05, 2025.

Brief Summary: Type 1 diabetes is an autoimmune disease where the body attacks the insulin-producing cells in the pancreas. In the absence of insulin, the body is unable to effectively use glucose for energy, resulting in high blood sugar levels. This leads to a lifelong need for intensive insulin therapy to manage blood sugar and prevent complications arising from elevated blood glucose levels. When insulin is low, the body produces ketone bodies. If ketone levels rise too high, they can lead to the dangerous condition known as d...